Rapid Novor
Rapid Novor helps biotech and pharmaceutical companies extract the full potential of antibodies in ways never before possible. Through next generation protein sequencing, Rapid Novor enables timely and reliable discovery and development of novel reagents, diagnostics, and therapeutics-to benefit those suffering from hard-to treat diseases. Our next generation protein sequencing (NGPS) technology has empowered thousands of researchers and has the potential to unlock a new universe of discoveries that will shape future research, and benefit global health. It is our goal to make NGPS as widely utilized as nucleotide-based technologies.
We are a technology development company and specialty services company combined. We empower researchers with access to cutting-edge antibody discovery and sequence analysis services, and help them characterize the immune response. We also pioneer the development of new technologies to decode immunity, and tests to monitor immune responses and improve patients’ lives.
We develop our own software, technology and methods through seamless integration of bioinformatics teams, mass spectrometry labs and deep research. Such integration gives our clients access to insights that only we can provide. It fuels the continuous innovation and refinement behind the high quality, reliable results and unparalleled abilities our clients have come to expect. Rapid Novor is home to the largest privately funded Mass Spectrometry-based proteomics facility in Canada, and has completed more antibody sequencing projects than any other team in the industry. Our team has over twenty years of experience specializing in proteomics, bioinformatics and Big Data processing.
Our technology continues to benefit 18/20 top pharmaceutical companies, and we have successfully fully and accurately sequenced over 8000 antibody and protein sequencing projects. We offer the following solutions:
- REmAb: Monoclonal Antibody Protein Sequencing
- REpAb: Antibody Discovery and Polyclonal Antibody Protein Sequencing
- MATCHmAb: Antibody Sequence Confirmation
- HDX-MS Epitope Mapping – Mass spectrometry-based epitope mapping
- SPR Analysis – Kinetic profiling
Featured Products
- REmAb – Next Generation Protein Sequencing providing an end to end full coverage sequence with unparalleled accuracy, 100% of the time
- REpAb – Polyclonal Antibody Sequencing analysis of antibody proteins directly from a complex mixture, using only mass spectrometry.
- HDX-MS Epitope Mapping – Mass spectrometry based epitope mapping service, that can identify the binding site of an antibody to its corresponding antigen with the highest confidence and resolution.
- SPR Analysis – Full kinetic profiling using our expertise in SPR analysis for antibodies.
Product Categories
Services
Antibody Sequencing
REmAb® de novo monoclonal antibody sequencing from small antibody samples, no need for hybridoma or DNA information. 100% accurate sequence in record time.
Protein Sequencing
REmAb® full coverage protein sequence with unparalleled accuracy, 100% of the time. World-leading abilities to purify samples and deal with unexpected PTM (even in the CDR region).
Antibody Discovery
Our discovery process offers a complete suite of services to take you from immunization and de novo polyclonal antibody (pAb) sequencing, through to recombinant mAb expression, mAb characterization and ultimately lead selection.
Our unique technology gives us the ability to sequence antibody proteins directly from a complex mixture, using only mass spectrometry. We call this REpAb®. Leverage the entire natural immune response and begin the search for your lead molecule directly from functional native circulating antibodies.
HDX-MS Epitope Mapping
Mass spectrometry-based epitope mapping. Epitope mapping to identify the binding site of an antibody to its corresponding antigen with the highest confidence and resolution.
Surface Plasmon Resonance
Our method for label free evaluation of antibody-antigen binding and biomolecular interaction relies on a Surface Plasmon Resonance analysis technology from Nicoya called OpenSPR. This nanotechnology-based SPR platform enables immobilization of binding partners in both orientations on the sensor chip with low levels for bulk shift even in most complex buffers. Combined with our expertise in antibody interactions, this results in high sensitivity and the lowest noise even in complex analytes.
More Proteomics Services
Proteomics CRO Rapid Novor offers a large suite of proteomics services that enable scientist to progress their research through mass spectrometry based research services.
- de novo antibody and protein sequencing
- HDX-MS epitope mapping
- Label-free binding kinetics analysis through SPR
- Antibody discovery through polyclonal antibody sequencing
Contact Us
The Krishgen support team strives to provide swift responses and resolution to your queries.